Showing results (51-60 of 213) with videos related to
Sort By:
Pageof 22
Journal of Virology|September 7, 2012
Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decouplingVictoria Furió, Raquel Garijo, María Durán, et al.Frontiers in Genetics|September 25, 2013
Exploiting tumor epigenetics to improve oncolytic virotherapyNicole E Forbes, Hesham Abdelbary, Mathieu Lupien, et al.Analytical Chemistry|May 24, 2011
Viral quantitative capillary electrophoresis for counting intact virusesGleb G Mironov, Alexey V Chechik, Rachel Ozer, et al.Oncolytic Virotherapy|August 12, 2016
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)Caroline J Breitbach, John C Bell, Tae-Ho Hwang, et al.Current Cancer Drug Targets|February 9, 2017
Oncolytic Viruses: The Best is Yet to ComeChantal G Lemay, Brian A Keller, Robert E Edge, et al.The Journal of Biological Chemistry|April 2, 2005
Internal translation initiation mediated by the angiogenic factor Tie2Eun-Hee Park, Joseph M Lee, Jaime D Blais, et al.International Journal of Molecular Sciences|January 21, 2023
Extracellular Vesicles and Viruses: Two Intertwined EntitiesColine Moulin, Mathieu J F Crupi, Carolina S Ilkow, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2013
Targeting and killing of metastatic cells in the transgenic adenocarcinoma of mouse prostate model with vesicular stomatitis virusMaryam Moussavi, Howard Tearle, Ladan Fazli, et al.Cytokine & Growth Factor Reviews|March 27, 2010
Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic virusesNaomi De Silva, Harold Atkins, David H Kirn, et al.Cancer Cell International|June 19, 2012
Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agentNehad M Alajez, Joseph D Mocanu, Tiffany Krushel, et al.Pageof 22